Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-20

Clinical Trial Update: The Role of Coadministration of Lidocaine and Ketamine in Opioid-Refractory Chronic Cancer-Related Pain. [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 study evaluating the coadministration of lidocaine and ketamine for opioid-refractory chronic cancer-related pain; the trial is not yet recruiting and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketamine (ketamine)
  • Lidocaine (Lidocaine)

Snippet

Sponsor: National and Kapodistrian University of Athens | Conditions: Opioid-Refractory Chronic Cancer-Related Pain | EARLY_Phase 1 | Status: NOT_YET_RECRUITING